137 related articles for article (PubMed ID: 19696160)
21. Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6.
Micic D; Macut D; Sumarac-Dumanovic M; Kendereski A; Popovic V; Deghenghi R; Dieguez C; Casanueva FF
Eur J Endocrinol; 2002 Dec; 147(6):761-6. PubMed ID: 12457451
[TBL] [Abstract][Full Text] [Related]
22. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
[TBL] [Abstract][Full Text] [Related]
23. Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man.
Pinto AC; Finamor FE; Lengyel AM
Clin Endocrinol (Oxf); 1999 Oct; 51(4):409-14. PubMed ID: 10583306
[TBL] [Abstract][Full Text] [Related]
24. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
25. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
Veldhuis JD; Bowers CY
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
[TBL] [Abstract][Full Text] [Related]
26. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
[TBL] [Abstract][Full Text] [Related]
27. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
[TBL] [Abstract][Full Text] [Related]
28. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
29. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
30. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.
Frieboes RM; Antonijevic IA; Held K; Murck H; Pollmächer T; Uhr M; Steiger A
Psychoneuroendocrinology; 2004 Aug; 29(7):851-60. PubMed ID: 15177700
[TBL] [Abstract][Full Text] [Related]
31. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
Grugni G; Guzzaloni G; Morabito F
J Endocrinol Invest; 2001 May; 24(5):340-8. PubMed ID: 11407654
[TBL] [Abstract][Full Text] [Related]
32. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
[TBL] [Abstract][Full Text] [Related]
33. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
[TBL] [Abstract][Full Text] [Related]
34. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
[TBL] [Abstract][Full Text] [Related]
35. Pituitary enlargement due to primary hypothyroidism: growth hormone response to GHRH, GHRP-6 and GHRH plus GHRP-6.
Damjanović S; Popović V; Petakov M; Djurović M; Dieguez C; Casanueva FF
J Pediatr Endocrinol Metab; 1996; 9(5):549-53. PubMed ID: 8961133
[TBL] [Abstract][Full Text] [Related]
36. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.
Van Dam PS; Smid HE; de Vries WR; Niesink M; Bolscher E; Waasdorp EJ; Dieguez C; Casanueva FF; Koppeschaar HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4706-11. PubMed ID: 11134132
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
Racine MS; Symons KV; Foster CM; Barkan AL
J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
[TBL] [Abstract][Full Text] [Related]
38. Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs.
Bhatti SF; Duchateau L; Van Ham LM; De Vliegher SP; Mol JA; Rijnberk A; Kooistra HS
Vet J; 2006 Nov; 172(3):515-25. PubMed ID: 15951209
[TBL] [Abstract][Full Text] [Related]
39. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
[TBL] [Abstract][Full Text] [Related]
40. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
